STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 96 filers reported holding STOKE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $284,630 | -2.6% | 72,241 | +162.8% | 0.00% | – |
| Q2 2023 | $292,187 | +126.0% | 27,487 | +77.1% | 0.00% | – |
| Q1 2023 | $129,298 | -57.3% | 15,522 | +7.7% | 0.00% | – |
| Q1 2022 | $303,000 | -77.5% | 14,409 | -74.4% | 0.00% | – |
| Q4 2021 | $1,348,000 | +5.3% | 56,180 | +11.6% | 0.00% | – |
| Q3 2021 | $1,280,000 | -22.0% | 50,348 | +3.3% | 0.00% | – |
| Q2 2021 | $1,641,000 | -10.2% | 48,742 | +3.5% | 0.00% | – |
| Q1 2021 | $1,828,000 | -40.2% | 47,073 | -4.7% | 0.00% | – |
| Q4 2020 | $3,058,000 | +295.6% | 49,382 | +114.1% | 0.00% | – |
| Q3 2020 | $773,000 | +126.7% | 23,067 | +61.3% | 0.00% | – |
| Q2 2020 | $341,000 | +15.6% | 14,300 | +11.2% | 0.00% | – |
| Q1 2020 | $295,000 | – | 12,861 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 16,786,713 | $562,187,000 | 75.80% |
| RTW INVESTMENTS, LP | 3,544,248 | $118,697,000 | 2.86% |
| Cormorant Asset Management, LP | 1,537,807 | $51,501,000 | 1.98% |
| Redmile Group, LLC | 2,549,506 | $85,383,000 | 1.57% |
| Birchview Capital, LP | 40,000 | $1,340,000 | 0.45% |
| HighVista Strategies LLC | 17,082 | $572,000 | 0.42% |
| Perceptive Advisors | 671,978 | $22,505,000 | 0.33% |
| GILDER GAGNON HOWE & CO LLC | 1,490,153 | $49,905,000 | 0.31% |
| Artal Group S.A. | 270,750 | $9,067,000 | 0.22% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 323 | $11,000 | 0.20% |